Skip to content
Home/Companies/MedTech/Unchained Labs
Unchained Labs

Unchained Labs

MedTech·US·Active
Entry
–
Hold
–
Status
Active

Who owns Unchained Labs?

Unchained Labs is currently owned by The Carlyle Group through Carlyle Sub-Saharan Africa Fund (2018 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQUnited States
SectorMedTech
Websitewww.unchainedlabs.com

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
HospitalityUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
HealthcareUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to
Amrod
Amrod
Exited 2023
ConsumerUS
to
CMC Networks
CMC Networks
Active
TelecomSouth Africa

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Appasamy
Appasamy
Active
Warburg PincusIndia
Argá Medtech SA
Argá Medtech SA
Active
Enterprise IrelandSwitzerland
Track Unchained Labs

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Unchained Labs?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Unchained Labs.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue